鈥� More than 15 years experience in tumor immunology,cell biology, molecular biology and virology
鈥� Research experience in academia and pharmaceutical industry
鈥� In depth knowledge for the preclinical evaluation of novel small- and large molecule drug candidates, particularly antibodies as anti-tumor agents,
鈥� Recent focus is the identification, characterization and validation of novel targets for ant-tumor therapies
鈥� Evaluation of cancer immune therapeutic approaches such as:
- redirection of pathogen specific T-cells against cancer (initiation and development of the concept and design of proof of concept experiments)
- in vivo efficacy of T-cell-activating-bispecific (TCB) mol
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
